FELDENE Drug Patent Profile

✉ Email this page to a colleague

When do Feldene patents expire, and when can generic versions of Feldene launch?

Feldene is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in FELDENE is piroxicam. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Feldene

A generic version of FELDENE was approved as piroxicam by TEVA on December 11^th, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for FELDENE?
What are the global sales for FELDENE?
What is Average Wholesale Price for FELDENE?

Summary for FELDENE

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	160
Clinical Trials:	2
Drug Prices:	Drug price information for FELDENE
What excipients (inactive ingredients) are in FELDENE?	FELDENE excipients list
DailyMed Link:	FELDENE at DailyMed

Drug patent expirations by year for FELDENE

Recent Clinical Trials for FELDENE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cairo University	Early Phase 1
Pamukkale University	Phase 4

See all FELDENE clinical trials

US Patents and Regulatory Information for FELDENE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-002	Apr 6, 1982	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-003	Apr 6, 1982	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FELDENE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-003	Apr 6, 1982	⤷ Sign Up	⤷ Sign Up
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-003	Apr 6, 1982	⤷ Sign Up	⤷ Sign Up
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-002	Apr 6, 1982	⤷ Sign Up	⤷ Sign Up
Pfizer	FELDENE	piroxicam	CAPSULE;ORAL	018147-002	Apr 6, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for FELDENE

See the table below for patents covering FELDENE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
German Democratic Republic	137104	VERFAHREN ZUR HERSTELLUNG VON 2-PYRIDYL-ODER 2-THIAZOLYL-DERIVATEN VON 3,4-DIHYDRO-2-METHYL-4-OXO-2H,1,2-BENZOTHIAZIN-3-CARBOXAMID-1,1-DIOXID	⤷ Sign Up
Denmark	255577		⤷ Sign Up
Canada	1077934	PREPARATION DU 1,1-DIOXYDE DE L'ACIDE 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTHIAZINE-3-CARBOXYLIQUE, ET SON EMPLOI COMME INTERMEDIAIRE (PROCESS FOR THE PREPARATION OF 3, 4-DIHYDRO-2-METHYL-4-OXO-2H-1, 2-BENZOTHIAZINE-3-CARBOXYLIC -1, 1-DIOXIDE AND ITS USE AS AN INTERMEDIATE)	⤷ Sign Up
Ireland	44998	PROCESS FOR TJE PREPARATION OF N-(2-PYRIDYL)-AND N(2-THIAZOLYL)-3,4-DIHYDRO-I-METHYL-4-OXO-2H-1,2-BENZOTHIAZINE-3-CABOXAMIDE-1,1-DIOXIDE AND NOVEL REACTIVE DERIVATIVES OF 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTHIAZINE-3-CARBOXYLIC ACID-1,1-DIOXIDE USED IN SAME	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for FELDENE

Recent Clinical Trials for FELDENE

Make Better Decisions: Try a trial or see plans & pricing